This clearly written perspective aimed at a broad audience is from HIV/AIDS researcher David Ho of the Aarron Diamond Research Centre. He applauds the goals of the newly launched Global Vaccine Enterprise for the creation of an HIV vaccine, but raises the general concern that the kind of scientific breakthrough that will be needed to make such an enterprise successful is likely to come from ‘curiosity-driven’ fundamental research, and that safeguards need to be in place to prevent the stifling of individuals and small teams working outside of the Global Vaccine Enterprise.


Related topics